Lymphoproliferative Disorder Involving the Cervix in a Patient Being Treated with FK-506

Author： Sunyecz J.A.   Price F.V.   Trucco G.   Thomas R.   Swerdlow S.H.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.62, Iss.2, 1996-08, pp. : 301-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FK506 Binding Proteins as Targets in Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 651-656

Bentham Science Publishers

Access to resources Recommend Favorite

The management of posttransplant lymphoproliferative disorder

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 125-136

Humana Press, Inc

Access to resources Recommend Favorite

COUNTERPOINT: Test the value of hyperthermia in patients with carcinoma of the cervix being treated with concurrent chemotherapy and radiation

By Prosnitz L.   Jones E.  

International Journal of Hyperthermia, Vol. 18, Iss. 1, 2002-01 ,pp. : 13-18

Informa Healthcare

Access to resources Recommend Favorite

IL15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 37-42

Spandidos Publications

Access to resources Recommend Favorite

Combined treatment with FK506 and nerve growth factor for spinal cord injury in rats

By Chen Guang   Zhang Zhen   Wang Shouyu   Lv Decheng  

Experimental and Therapeutic Medicine, Vol. 6, Iss. 4, 2013-10 ,pp. : 868-872

Spandidos Publications

Access to resources Recommend Favorite